Centessa Pharmaceuticals plc
CNTA
$12.30
$0.4653.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -202.22% | -10.14% | -76.07% | 24.98% | 14.68% |
| Total Depreciation and Amortization | -11.76% | -4.65% | -1.18% | 132.43% | 183.33% |
| Total Amortization of Deferred Charges | -2.78% | 1.32% | 0.00% | 196.15% | -- |
| Total Other Non-Cash Items | 380.16% | 65.90% | 160.90% | 7.76% | 65.00% |
| Change in Net Operating Assets | 831.86% | 376.58% | -21.55% | -47.80% | 75.20% |
| Cash from Operations | -37.84% | 42.80% | 7.90% | 22.06% | 39.78% |
| Capital Expenditure | 100.00% | 20.93% | -- | -- | 95.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 237.01% | -7.69% | 21.99% | 119.43% | -8,957.77% |
| Cash from Investing | 236.80% | -7.68% | 22.00% | 119.41% | -3,997.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -16.49% | 1,574.94% | 900,516.67% | -- | 7,047.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -53.42% | 1,568.36% | 877,508.33% | -- | 7,047.19% |
| Foreign Exchange rate Adjustments | 701.59% | -965.45% | -131.50% | -57.72% | -169.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.84% | 918.55% | 107.98% | 92.66% | 15.10% |